SMTL ID : 3tl5.1

Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor for the Treatment of Cancer

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.79 Å
Oligo State
monomer
Ligands
1 x 980: (2S)-1-(4-{[2-(2-aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}piperazin-1-yl)-2-hydroxypropan-1-one(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Sutherlin, D.P. et al., Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer. J.Med.Chem. (2011)
Release Date
2011-11-02
Peptides
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform

Related Entries With Identical Sequence

3csf.1 | 3cst.1 | 3l08.1 | 3l08.2 | 3l16.1 | 3l17.1 | 3oaw.1 | 3pre.1 | 3prz.1 | 3ps6.1 | 3r7q.1 | 3r7r.1 | 3t8m.1 | 3zvv.1 | 3zw3.1 | 4fa6.1 | 4fad.1 | 4g11.1 | 4gb9.1 | 4hle.1 | 4j6i.1 | 4urk.1 | 5t23.1 | 6fh5.1 | 6gq7.1 | 6t3b.1 | 6t3c.1 | 7jwe.1 | 7jwz.1 | 7jx0.1  more...